Panagora Asset Management’s Alimera Sciences ALIM Stock Holding History

Panagora Asset Management’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-34	Closed	–	–	2664
2019 Q2	$0	Buy	+34	New	+$479	﹤0.01%	2689

Other funds holding ALIM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Panagora Asset Management's ALIM Position: Q3 2019 in Review

Panagora Asset Management sold out of Alimera Sciences (ALIM) in Q3 2019, closing a stake of 34 shares.

Panagora Asset Management first reported a position in ALIM in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 32 funds tracked by Wall St. Rank hold ALIM as of Q3 2019.

Panagora Asset Management reported no remaining Alimera Sciences position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 34 Alimera Sciences shares in Q3 2019.
Panagora Asset Management first reported a position in Alimera Sciences in Q2 2019 and held it in 1 quarter.
Panagora Asset Management's Alimera Sciences position peaked at $0 in Q2 2019.
32 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.